Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
Nowadays prostate cancer is the most common solid tumor in men from industrialized countries and the second leading cause of death. At the ages when PCa is usually diagnosed, mortality related to cardiovascular morbidity is high; therefore, men at risk for PCa frequently receive chronic lipid-loweri...
Main Authors: | M. Olivan, M. Rigau, E. Colás, M. Garcia, M. Montes, T. Sequeiros, L. Regis, A. Celma, J. Planas, J. Placer, J. Reventós, I. de Torres, A. Doll, J. Morote |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/762178 |
Similar Items
-
Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
by: Juan Morote, et al.
Published: (2014-08-01) -
Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues
by: Tamara Sequeiros, et al.
Published: (2013-01-01) -
The Present and Future of Prostate Cancer Urine Biomarkers
by: Jeremy Clark, et al.
Published: (2013-06-01) -
Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
by: Mark A Moyad, et al.
Published: (2015-01-01) -
The role of interleukin-8 in the tumorigenicity of prostate cancer
by: Hamill, M. A.
Published: (2004)